Ofatumumab (Arzerra)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Ofatumumab (Arzerra), covering 2014-07-30 to 2025-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant [Phase 2]